Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003–2013)
ABSTRACT BACKGROUND The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-l...
Saved in:
Published in | Canadian Medical Association journal (CMAJ) Vol. 190; no. 41; pp. E1221 - E1226 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Joule Inc
15.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT BACKGROUND The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-level changes in sexual behaviours before and after implementation of the school-based HPV vaccination program in British Columbia. METHODS In 2008, a school-based HPV vaccination program for girls was introduced in British Columbia. Using data from the BC Adolescent Health Survey — a longitudinal provincial survey administered in schools to capture adolescent physical and emotional health indicators, we conducted a linear trend analysis on sexual health behaviours and risk factors in adolescent girls before and after the implementation of vaccination for HPV (2003, 2008 and 2013). RESULTS We analyzed data for 298 265 girls who self-identified as heterosexual. The proportion of girls reporting ever having sexual intercourse decreased from 21.3% (2003) to 18.3% (2013; adjusted odds ratio [OR] 0.79). Self-report of sexual intercourse before the age of 14 years decreased significantly from 2008 to 2013 (adjusted OR 0.76), as did reported substance use before intercourse (adjusted OR for 2003–2013 0.69). There was no significant change in the number of sexual partners reported (2003–2013). Between 2003 and 2013, girls’ reported use of contraception and condoms increased, while pregnancy rates decreased. INTERPRETATION Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours. |
---|---|
AbstractList | INTERPRETATION: Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours. BACKGROUNDThe human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-level changes in sexual behaviours before and after implementation of the school-based HPV vaccination program in British Columbia.METHODSIn 2008, a school-based HPV vaccination program for girls was introduced in British Columbia. Using data from the BC Adolescent Health Survey - a longitudinal provincial survey administered in schools to capture adolescent physical and emotional health indicators, we conducted a linear trend analysis on sexual health behaviours and risk factors in adolescent girls before and after the implementation of vaccination for HPV (2003, 2008 and 2013).RESULTSWe analyzed data for 298 265 girls who self-identified as heterosexual. The proportion of girls reporting ever having sexual intercourse decreased from 21.3% (2003) to 18.3% (2013; adjusted odds ratio [OR] 0.79). Self-report of sexual intercourse before the age of 14 years decreased significantly from 2008 to 2013 (adjusted OR 0.76), as did reported substance use before intercourse (adjusted OR for 2003-2013 0.69). There was no significant change in the number of sexual partners reported (2003-2013). Between 2003 and 2013, girls' reported use of contraception and condoms increased, while pregnancy rates decreased.INTERPRETATIONSince the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours. BACKGROUND: The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-level changes in sexual behaviours before and after implementation of the school-based HPV vaccination program in British Columbia. METHODS: In 2008, a school-based HPV vaccination program for girls was introduced in British Columbia. Using data from the BC Adolescent Health Survey--a longitudinal provincial survey administered in schools to capture adolescent physical and emotional health indicators, we conducted a linear trend analysis on sexual health behaviours and risk factors in adolescent girls before and after the implementation of vaccination for HPV (2003, 2008 and 2013). RESULTS: We analyzed data for 298265 girls who self-identified as heterosexual. The proportion of girls reporting ever having sexual intercourse decreased from 21.3% (2003) to 18.3% (2013; adjusted odds ratio [OR] 0.79). Self-report of sexual intercourse before the age of 14 years decreased significantly from 2008 to 2013 (adjusted OR 0.76), as did reported substance use before intercourse (adjusted OR for 2003-2013 0.69). There was no significant change in the number of sexual partners reported (2003-2013). Between 2003 and 2013, girls' reported use of contraception and condoms increased, while pregnancy rates decreased. INTERPRETATION: Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours. ABSTRACT BACKGROUND The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-level changes in sexual behaviours before and after implementation of the school-based HPV vaccination program in British Columbia. METHODS In 2008, a school-based HPV vaccination program for girls was introduced in British Columbia. Using data from the BC Adolescent Health Survey — a longitudinal provincial survey administered in schools to capture adolescent physical and emotional health indicators, we conducted a linear trend analysis on sexual health behaviours and risk factors in adolescent girls before and after the implementation of vaccination for HPV (2003, 2008 and 2013). RESULTS We analyzed data for 298 265 girls who self-identified as heterosexual. The proportion of girls reporting ever having sexual intercourse decreased from 21.3% (2003) to 18.3% (2013; adjusted odds ratio [OR] 0.79). Self-report of sexual intercourse before the age of 14 years decreased significantly from 2008 to 2013 (adjusted OR 0.76), as did reported substance use before intercourse (adjusted OR for 2003–2013 0.69). There was no significant change in the number of sexual partners reported (2003–2013). Between 2003 and 2013, girls’ reported use of contraception and condoms increased, while pregnancy rates decreased. INTERPRETATION Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours. The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-level changes in sexual behaviours before and after implementation of the school-based HPV vaccination program in British Columbia. In 2008, a school-based HPV vaccination program for girls was introduced in British Columbia. Using data from the BC Adolescent Health Survey - a longitudinal provincial survey administered in schools to capture adolescent physical and emotional health indicators, we conducted a linear trend analysis on sexual health behaviours and risk factors in adolescent girls before and after the implementation of vaccination for HPV (2003, 2008 and 2013). We analyzed data for 298 265 girls who self-identified as heterosexual. The proportion of girls reporting ever having sexual intercourse decreased from 21.3% (2003) to 18.3% (2013; adjusted odds ratio [OR] 0.79). Self-report of sexual intercourse before the age of 14 years decreased significantly from 2008 to 2013 (adjusted OR 0.76), as did reported substance use before intercourse (adjusted OR for 2003-2013 0.69). There was no significant change in the number of sexual partners reported (2003-2013). Between 2003 and 2013, girls' reported use of contraception and condoms increased, while pregnancy rates decreased. Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours. |
Audience | Professional |
Author | Naus, Monika, MD MHSc Pedersen, Heather N., MPH Ogilvie, Gina S., MD DrPH Dobson, Simon R., MD Phan, Felicia, MPH Saewyc, Elizabeth M., PhD RN |
Author_xml | – sequence: 1 fullname: Ogilvie, Gina S., MD DrPH – sequence: 2 fullname: Phan, Felicia, MPH – sequence: 3 fullname: Pedersen, Heather N., MPH – sequence: 4 fullname: Saewyc, Elizabeth M., PhD RN – sequence: 5 fullname: Dobson, Simon R., MD – sequence: 6 fullname: Naus, Monika, MD MHSc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30322986$$D View this record in MEDLINE/PubMed |
BookMark | eNqVk8tu1DAUhiNURC-wYo8skFArlMGXTOJskKqKS6UKEIW1dcY5mfHg2FM7GbU7VrwAb8iT4GhK6UizwV4c2f78-9jn92G257zDLHvK6IRNqXitO1hOmKQllw-yA1ZImXPB673sgEpOc1EX5X52GOOSpiZ49SjbFynyWpYH2c_PfjVY6I13ucU1WhLxegBLZriAtfFDiMQ4Ao23GDW6nsxNsDEttz4gAdcQaHsMCeqDbwY9KhHfkn6BZDF04MgKVsZa3yW5MESyBq2NQ3LMUza_f_zilImTx9nDFmzEJ7fxKPv27u3Xsw_5xaf352enF7me1lWfa1HPKNMVsJnEoihbKrABRnVZpzFAQWXbVlSWjBaiLCtRc9bADDDtYlA24ih7s9FdDbMOm_FCAaxaBdNBuFEejNpecWah5n6tSiZlXVRJ4PhWIPirAWOvOpPexVpw6IeoOOO0mk5lOv8oe7FB52BRGdf6pKhHXJ1Op1Vds5KKROU7qDk6TMenQrcmTW_xz3fwemWu1H1osgNKvcHO6J2qJ1sbEtPjdT-HIUZ1fvnlP9iP2-zLe-wCwfaL6O0wuiRug682oA4-xoDtXU0YVaPN1WhztbF5op_dL-Md-9fX_-qMyUxrg0Fpa5zRYL_jDcZl8rVLPlNMRa6ouhx_yvhRmBS04imhP6oRDL8 |
CitedBy_id | crossref_primary_10_1136_sextrans_2019_054311 crossref_primary_10_1016_j_jadohealth_2019_07_003 crossref_primary_10_1371_journal_pone_0234693 crossref_primary_10_3390_vaccines12020114 crossref_primary_10_1007_s00148_023_00942_4 crossref_primary_10_1007_s10865_022_00372_9 crossref_primary_10_1007_s10508_019_1411_z crossref_primary_10_15570_actaapa_2019_38 crossref_primary_10_3390_pathogens13030209 crossref_primary_10_1186_s12889_019_7134_1 crossref_primary_10_1093_heapol_czaa083 crossref_primary_10_1007_s00112_018_0632_x crossref_primary_10_1016_j_vaccine_2019_11_044 crossref_primary_10_1136_bmj_l580 crossref_primary_10_1007_s42650_024_00084_2 crossref_primary_10_1016_j_nwh_2021_09_006 |
ContentType | Journal Article |
Copyright | Joule Inc. or its licensors 2018 Joule Inc. or its licensors. COPYRIGHT 2018 Joule Inc. 2018 Joule Inc. or its licensors 2018 |
Copyright_xml | – notice: Joule Inc. or its licensors – notice: 2018 Joule Inc. or its licensors. – notice: COPYRIGHT 2018 Joule Inc. – notice: 2018 Joule Inc. or its licensors 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISN ISR 7X8 5PM |
DOI | 10.1503/cmaj.180628 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Canada Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1488-2329 |
EndPage | E1226 |
ExternalDocumentID | A557991603 10_1503_cmaj_180628 30322986 1_s2_0_S0820394618307260 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | British Columbia Canada |
GeographicLocations_xml | – name: British Columbia – name: Canada |
GrantInformation_xml | – fundername: CIHR grantid: MOP 119472 |
GroupedDBID | --- .1- .55 .FO .XZ 00U 18M 1P~ 29B 2QL 2WC 354 36B 3O- 3V. 4.4 4IJ 53G 5GY 5RS 6PF 7RV 7X7 88E 88I 8AF 8AO 8F7 8FI 8FJ 8FQ 8G5 AAKAS AAWTL ABIVO ABOCM ABPMR ABUWG ACGOD ACIHN ADBBV ADZCM AEAQA AENEX AEVXI AFCHL AFCTW AFKRA AFRHN AHMBA AI. AJUYK ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI ASPBG AVWKF AZFZN AZQEC BAWUL BCGST BENPR BKEYQ BNQBC BPHCQ BVXVI C1A C45 CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EMB EMOBN EX3 F5P FEDTE FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 H13 HCIFZ HMCUK HVGLF HYE IAO ICQ ICW IEA IHR IHW INH INR IOF IPT ISN ISR ITC L7B M0T M1P M2M M2O M2P M2Q M3C M3G M5~ N4W NAPCQ OBH OCB OD. ODZKP OFXIZ OGEVE OHH OO~ OVD OVIDX P2P PCD PQQKQ PROAC PSQYO PSYQQ PV9 Q2X RDH RHF RHI RPM RZL SV3 TEORI U5U UHU UKHRP VH1 VVN WH7 WOQ WOW X6Y X7M YFH YOC Z5R ZGI ZXP ~H1 CGR CUY CVF ECM EIF NPM AAYXX AFPKN CITATION ABPTK 7X8 5PM |
ID | FETCH-LOGICAL-c597t-c39b01c7a1b8e446f03eda10c698e4aa408ff708610436673921dabaeb011a6d3 |
IEDL.DBID | RPM |
ISSN | 0820-3946 |
IngestDate | Tue Sep 17 21:23:19 EDT 2024 Sat Oct 26 05:51:06 EDT 2024 Thu Feb 22 23:57:19 EST 2024 Thu Nov 14 20:51:33 EST 2024 Tue Dec 12 21:18:43 EST 2023 Tue Nov 12 23:14:25 EST 2024 Thu Aug 01 19:14:20 EDT 2024 Thu Aug 01 19:17:04 EDT 2024 Tue Aug 20 22:12:08 EDT 2024 Fri Aug 23 02:44:49 EDT 2024 Sat Nov 02 12:24:37 EDT 2024 Tue Oct 15 22:56:03 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 41 |
Language | English |
License | 2018 Joule Inc. or its licensors. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c597t-c39b01c7a1b8e446f03eda10c698e4aa408ff708610436673921dabaeb011a6d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.cmaj.ca/content/cmaj/190/41/E1221.full.pdf |
PMID | 30322986 |
PQID | 2120755804 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6188947 proquest_miscellaneous_2120755804 gale_infotracmisc_A557991603 gale_infotracgeneralonefile_A557991603 gale_infotraccpiq_557991603 gale_infotracacademiconefile_A557991603 gale_incontextgauss_ISR_A557991603 gale_incontextgauss_ISN_A557991603 gale_healthsolutions_A557991603 crossref_primary_10_1503_cmaj_180628 pubmed_primary_30322986 elsevier_clinicalkeyesjournals_1_s2_0_S0820394618307260 |
PublicationCentury | 2000 |
PublicationDate | 2018-10-15 |
PublicationDateYYYYMMDD | 2018-10-15 |
PublicationDate_xml | – month: 10 year: 2018 text: 2018-10-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada |
PublicationTitle | Canadian Medical Association journal (CMAJ) |
PublicationTitleAlternate | CMAJ |
PublicationYear | 2018 |
Publisher | Joule Inc |
Publisher_xml | – name: Joule Inc |
SSID | ssj0000327 |
Score | 2.406649 |
Snippet | ABSTRACT BACKGROUND The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern... The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination... BACKGROUND: The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV... INTERPRETATION: Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or... BACKGROUNDThe human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV... |
SourceID | pubmedcentral proquest gale crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | E1221 |
SubjectTerms | Adolescent Adolescent Behavior Age Factors British Columbia Care and treatment Coitus Complications and side effects Condoms - trends Contraception Behavior - trends Diagnosis Female Humans Immunization Programs Internal Medicine Odds Ratio Papillomavirus infections Papillomavirus Vaccines - therapeutic use Population Growth Precancerous conditions Pregnancy Pregnancy in Adolescence - statistics & numerical data Risk factors Risk-Taking School Health Services Self Report Sexual Behavior - statistics & numerical data Sexual Partners Vaccination Women |
Title | Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003–2013) |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0820394618307260 https://www.ncbi.nlm.nih.gov/pubmed/30322986 https://search.proquest.com/docview/2120755804 https://pubmed.ncbi.nlm.nih.gov/PMC6188947 |
Volume | 190 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61Rap6QbwxLWFBFY-Dm13b68exVC0FKVHUUim31e7aDpYc28QxZ078Af4hv4TZtR1i1APiEima8SbaeScz3yB0HCmIy07M7BTyedtTfmRLD5yhJKl0aEoUMej8k6l_eeN9mrP5DmL9LIxp2lcyOyny5UmRfTG9ldVSjfs-sfFscubTMIy8YLyLdkFB-xK9d79uu6c11KPBked3Q3mMuGO1FOAaQj02eID2wXk7TqSHqG-PSH-76K0YNeyf3ApIF_fQ3S6TxKftN76PdpLiAdqfdP-VP0Q_ZpvdXHauW4NwbeCVcTeZ36xqnBX4D6QTXmSrvAYy5LEJFkWMzQJxYFq3sLBwEi5TDCkjNqv9cCWqLM_LJRy3amr8TSj90fitbkX79f0nRH333SN0c3H--ezS7rYu2AqKi7Wt3EgSqgJBZZhAsZgSN4kFJSBGeC-ER8I0DaASohq93g8gwaKxkCKBp6jwY_cx2ivKInmKsEYPg4yQ0pgRT_qu9JhQIohk4rHIVaGFjvub51ULrsF1UQKy4lpWvJWVhYJeKryfFwUPl9SdudWc8trhhF9roWuZg58iAVRqFnqhhcjbmdKNMfNTxgKdGBPXQq8Mh4bCKHSvzUI0dc0_Xk__helqwPSmY0pL0AoluvkGuAoNsTXgPBxwqir7yreorwfURQs_ftsxRwNG8AtqQH7Zay7XJN1MVyRlU3PIViBRZCHxLPSk1eTN9fdGAXc-0PENg4YjH1LASg0seWeVz_77yUN0AIpp0IYpO0J761WTPIeUby1HYOjzYITuvD-fzq5G5ocTeP0wpyNj_L8B6HNZXA |
link.rule.ids | 230,315,730,783,787,867,888,27936,27937,31732,33757,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkUovFW_SFmpQBfSQrp3YeRyrimoL3VVFW6k3y3aSJVI2CZsNZ078Af4hv4RxHssG9YA4rmbirDxvZeYbhA5DDXHZibidQD5vM-2FtmLgDBVJlEMTokmDzj-ZeuMb9vGW324g3s_CNE37WqXHeTY_ztMvTW9lOdejvk9sdDk59WgQhMwf3UP3wV4J64v03gG77abWwAwHh8zrxvI4cUd6LsE5BGZwcBttgft2nNCMUd8dk_520mtRathBuRaSzh6inS6XxCftf36ENuL8MdqadF_Ln6Afl6vtXHZmmoNw1QAs4242v15UOM3xH1AnPEsXWQVkyGRjLPMINyvEgWnZAsPCSbhIMCSNuFnuh0tZpllWzOG4RV3hb1KbV-P3phnt1_efEPfdo6fo5uzD9enY7vYu2BrKi6Wt3VARqn1JVRBDuZgQN44kJSBI-C0lI0GS-FALUYNf7_mQYtFIKhnDU1R6kfsMbeZFHr9A2OCHQU5IacQJU56rGJda-qGKGQ9dHVjosL95UbbwGsKUJSArYWQlWllZyO-lIvqJUfBxcdUZXCWoqBxBxJURupE5eCriQ61moQMjRNFOla7MWZxw7pvUmLgWetNwGDCM3HTbzGRdVeL8avovTJ8HTO86pqQArdCym3CAqzAgWwPOvQGnLtOvYo36dkCdtQDkdx2zP2AEz6AH5Ne95gpDMu10eVzUlYB8BVJFDqZjoeetJq-uvzcKuPOBjq8YDCD5kAJ22gCTd3a5-99PHqAH4-vJhbg4n37aQ9ugpA32MOX7aHO5qOOXkAAu1avG3H8DFlZYSw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkaJeUHmbFrqgisfB9a6968exKkQtkCiiVOpttbu2gyXHduOEMyf-AP-QX8KsHyFGPSCO0YzX0c5bnvkGoaNIQ1x2Y26nkM_bTPuRrRg4Q0VS5dKUaNKg80-m_tkl-3DFr7ZWfTVN-1plx0W-OC6yr01vZbXQTt8n5swmpz4Nw4gFThWnzm10B2yW-H2h3jthr93WGpoB4Yj53WgeJ56jFxIcRGiGB3fRCFy460ZmlPrmuPS3o96KVMMuyq2wNN5Dd7t8Ep-0__seupUU99Fo0n0xf4B-zDYbuuzcNAjhugFZxt18_npZ46zAf4Cd8Dxb5jWQIZtNsCxi3KwRB6ZVCw4LJ-EyxZA44mbBH65kleV5uYDjlusaf5PavBq_MQ1pv77_hNjvvX2ILsfvv5ye2d3uBVtDibGytRcpQnUgqQoTKBlT4iWxpASECb-lZCRM0wDqIWow7P0A0iwaSyUTeIpKP_YeoZ2iLJInCBsMMcgLKY05Ycr3FONSyyBSCeORp0MLHfU3L6oWYkOY0gRkJYysRCsrCwW9VEQ_NQp-Lqk7o6sFFbUriLgwQjcyB29FAqjXLHRohCjaydKNSYsTzgOTHhPPQi8bDgOIUZiOm7lc17U4v5j-C9PnAdPrjiktQSu07KYc4CoM0NaAc3_AqavsWmxRXw2o8xaE_KZjDgaM4B30gPyi11xhSKalrkjKdS0gZ4F0kYeEWehxq8mb6--NAu58oOMbBgNKPqSArTbg5J1tPv3vJw_RaPZuLD6dTz_uo13Q0QZ-mPIDtLNarpNnkAOu1PPG2n8D7QVZXg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Population-level+sexual+behaviours+in+adolescent+girls+before+and+after+introduction+of+the+human+papillomavirus+vaccine&rft.jtitle=Canadian+Medical+Association+journal+%28CMAJ%29&rft.au=Ogilvie%2C+Gina+S&rft.au=Phan%2C+Felicia&rft.au=Pedersen%2C+Heather+N&rft.au=Dobson%2C+Simon+R&rft.date=2018-10-15&rft.pub=Joule+Inc&rft.issn=0820-3946&rft.eissn=1488-2329&rft.volume=190&rft.issue=41&rft.spage=E1221&rft_id=info:doi/10.1503%2Fcmaj.180628&rft.externalDocID=A557991603 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08203946%2FS0820394618X41005%2Fcov150h.gif |